Protagonist Therapeutics, Inc (PTGX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 234 transactions totaling $58.0M, demonstrating a bullish sentiment with $13.0M in net insider flow. The most recent transaction on Jan 27, 2026 involved a transaction of 5,000 shares valued at $0.
No significant insider buying has been recorded for PTGX in the recent period.
No significant insider selling has been recorded for PTGX in the recent period.
Based on recent SEC filings, insider sentiment for PTGX is bullish with an Insider Alignment Score of 61/100 and a net flow of $13.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Protagonist Therapeutics, Inc (PTGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PTGX stock, having executed 234 transactions in the past 90 days. The most active insider is Dinesh V. Ph D. Patel (Executive), who has made 60 transactions totaling $11.1M.
Get notified when executives and directors at PTGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Molina Arturo Md | Chief Medical Officer | Option Exercise | 5,000 | $N/A | $0 | |
| Jan 27, 2026 | Molina Arturo Md | Chief Medical Officer | Sale | 5,000 | $82.00 | $410.0K | |
| Jan 27, 2026 | Molina Arturo Md | Chief Medical Officer | Option Exercise | 5,000 | $8.04 | $40.2K | |
| Jan 26, 2026 | Molina Arturo Md | Chief Medical Officer | Option Exercise | 5,000 | $N/A | $0 | |
| Jan 26, 2026 | Molina Arturo Md | Chief Medical Officer | Sale | 5,000 | $82.28 | $411.4K | |
| Jan 26, 2026 | Molina Arturo Md | Chief Medical Officer | Option Exercise | 5,000 | $8.04 | $40.2K | |
| Jan 23, 2026 | Molina Arturo Md | Chief Medical Officer | Sale | 13,151 | $82.42 | $1.1M | Large |
| Jan 20, 2026 | Molina Arturo Md | Chief Medical Officer | Sale | 9,514 | $82.48 | $784.7K | Large |
| Jan 9, 2026 | E. Selick Harold | Executive | Option Exercise | 14,299 | $N/A | $0 | |
| Jan 9, 2026 | E. Selick Harold | Executive | Option Exercise | 14,299 | $4.21 | $60.2K | |
| Jan 2, 2026 | Molina Arturo Md | Chief Medical Officer | Award | 32,000 | $N/A | $0 | |
| Jan 2, 2026 | Molina Arturo Md | Chief Medical Officer | Award | 25,600 | $N/A | $0 | |
| Jan 2, 2026 | Ali Asif | Chief Financial Officer | Award | 32,000 | $N/A | $0 | C-Suite |
| Jan 2, 2026 | Ali Asif | Chief Financial Officer | Award | 25,600 | $N/A | $0 | C-Suite |
| Jan 2, 2026 | V. Ph D. Patel Dinesh | Executive | Award | 120,200 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 13 | $35.5M | 57.2% |
Sale(S) | 76 | $22.5M | 36.2% |
Exercise(M) | 60 | $2.7M | 4.3% |
Payment(F) | 12 | $1.3M | 2.2% |
Award(A) | 54 | $60.3K | 0.1% |
Gift(G) | 9 | $0 | 0.0% |
Conversion(C) | 10 | $0 | 0.0% |
Insiders at Protagonist Therapeutics, Inc are accumulating shares at an accelerated pace. With 22 insiders making 234 transactions totaling $35.5M in purchases versus $22.5M in sales, the net buying activity of $13.0M signals strong executive confidence. Dinesh V. Ph D. Patel (Executive) leads the buying activity with $11.1M in transactions across all time.